LipioJoint for Achilles Tendinitis

This trial tests a new treatment called LipioJoint to determine if it can safely reduce pain from chronic Achilles tendinitis. A doctor uses a small tube to inject a temporary blocker into blood vessels near the Achilles tendon. The trial aims to assess pain reduction over a year and monitor for any serious side effects. Suitable candidates for this trial include those who have experienced persistent Achilles tendinitis pain despite trying other treatments for at least three months and wish to avoid surgery. As a Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this new treatment.

The trial protocol does not specify if you need to stop taking your current medications. However, if you are on anticoagulants or have a blood clotting disorder, you may not be eligible to participate.

Research has shown that LipioJoint, a treatment for Achilles tendinopathy, is generally well-tolerated in early studies. Participants typically do not experience serious problems. Most individuals undergoing similar procedures, where a temporary blocking agent is injected into blood vessels, report no major issues. This treatment remains in the early testing stages, with the primary goal of ensuring its safety for people. While more information is needed to confirm long-term safety, early results appear promising for those considering joining a trial.¹²³⁴⁵

Unlike the standard of care for Achilles tendinitis, which typically involves rest, physical therapy, and sometimes anti-inflammatory medications or corticosteroid injections, LipioJoint is an innovative approach that uses embolization. This technique targets the blood vessels in the tendon, potentially reducing inflammation and pain more directly and effectively. Researchers are excited about LipioJoint because it offers a new mechanism of action that could provide relief faster and more sustainably than current treatments.

Research has shown that Lipiodol embolization, a procedure that blocks certain blood vessels, can help treat long-lasting tendon inflammation. Some studies found that this treatment reduces pain and improves movement. For example, people with chronic tendon issues reported less pain and better joint movement after the procedure. This trial will evaluate LipioJoint, based on this approach, as a promising option for managing Achilles tendinitis. While more research is needed, these early results offer encouragement for those seeking relief from ongoing tendon pain.²³⁶⁷⁸